Cake Mix Recall: Urgent Safety Alert & What to Do

by Grace Chen

Nationwide Cake Mix Recall Upgraded to Highest FDA Risk Level

A nationwide recall of cake mix products has been elevated to a Class I recall by the Food and Drug Administration (FDA), the agency’s most serious classification, due to undeclared allergens. The FDA initially issued the recall on December 23, but the upgrade signifies a heightened risk to public health.

FDA Recall: What Consumers Need to Know

The initial recall was prompted by the failure of B.C. Williams Bakery Service to declare the presence of milk as an allergen on product packaging. A Class I recall, as defined by the FDA, indicates “there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.” This escalation underscores the potential severity of the risk posed to individuals with milk allergies or sensitivities.

Affected Products and Lot Numbers

The recall encompasses three specific cake mix products, all packaged in 50 lb. multi-wall, kraft, poly-lined moisture proof bags. Consumers are urged to check their supplies for the following:

  • Spice Cake Mix: Batch 221
  • Bread and Roll Mix: Lot #072225-217, Lot #072225-218, Lot #080325-200, Lot #080325-201, Lot #081625-203, Lot #081625-204, Lot #092225-222, Lot #092225-223, Lot #092225-224, Lot #092225-225, Lot #092225-226, Lot #092225-227, Lot #092225-228, Lot #101725-208, and Lot #101725-209
  • Swiss Chocolate Cake Mix: Lot #072925-220 and Lot #071825-36

FDA Guidance for Consumers

The FDA strongly advises consumers who possess any of the recalled items to discard them immediately and refrain from consumption. According to the recall report, no further information was released regarding the scope of the issue or potential health impacts beyond the risk posed by the undeclared allergen.

This recall serves as a critical reminder of the importance of accurate allergen labeling and the potential dangers faced by those with food allergies. Consumers should remain vigilant and prioritize their health by adhering to the FDA’s guidance.

You may also like

Leave a Comment